Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOVA-NOA Trial: Leflutrozole for Non-Obstructive Azoospermia
2025-524774-42-00Phase 2Authorised
- Sponsor
- Herlev Hospital
- Start
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of leflutrozole in nonobstructive azoospermia (NOA), sponsored by Herlev Hospital. Primary endpoint: Proportion of patients with spermatozoa in the ejaculate at Week 12–20. Planned start Jun 2026; status: authorised.
02
Drugs
leflutrozole
03
Conditions
nonobstructive azoospermia (NOA)
Beyond the preview
Go deeper on 2025-524774-42-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2025-524774-42-00.